PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14522823-2	2004	Mucin release has been measured as [3H]glucosamine-labeled product in extracellular medium and as single-cell membrane capacitance increases indicative of exocytosis-related increases in membrane area.	Glucosamine	39-50	LOC100508689	Homo sapiens	0-5	
15985706-3	2005	Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.	Glucosamine	12-23	LOC100508689	Homo sapiens	133-138	
15527548-3	2004	Using [(3)H]glucosamine-labeled mucous acinar cells of sublingual salivary gland in culture, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited in a concentration-dependent manner by EGFR kinase inhibitor, PD153035, as well as wortmannin, an inhibitor of PI3K.	Glucosamine	12-23	LOC100508689	Homo sapiens	171-176	
9922317-6	1999	This reduction was associated with a 50% reduction in synthesis of mature glucosamine-labeled mucin, almost complete inhibition of secretion of sialyl-LeX and sialyl-Tn antigens, and a 40% decrease in binding of colon cancer cells to E-selectin.	Glucosamine	74-85	LOC100508689	Homo sapiens	94-99	
11754731-7	2002	Carbohydrate analyses of the purified mucin showed the presence of galactose, glucosamine, galactosamine, and sialic acid, but no mannose, glucose, or uronic acid.	Glucosamine	78-89	LOC100508689	Homo sapiens	38-43	
11425799-11	2001	The reduced sulfate:glucosamine ratio was largely due to increased incorporation of glucosamine into newly synthesized mucin rather than reduction in total sulfate incorporation.	Glucosamine	20-31	LOC100508689	Homo sapiens	119-124	
11425799-11	2001	The reduced sulfate:glucosamine ratio was largely due to increased incorporation of glucosamine into newly synthesized mucin rather than reduction in total sulfate incorporation.	Glucosamine	84-95	LOC100508689	Homo sapiens	119-124	
8729006-4	1996	Mucin was measured by [3H]-glucosamine labeling.	Glucosamine	27-38	LOC100508689	Homo sapiens	0-5	
8741012-2	1996	Mucin secretion was followed by measuring the release of [3H]-glucosamine metabolically labelled glycoproteins eluted in the void volume of Sepharose 4B column chromatography.	Glucosamine	62-73	LOC100508689	Homo sapiens	0-5	
9872504-4	1998	Biosynthesis of mucin was studied by labeling gastric mucosa for 2 h with [3H]-glucosamine.	Glucosamine	79-90	LOC100508689	Homo sapiens	16-21	
8006952-2	1994	Mucin secretion was measured as release of glucosamine-labeled macromolecules trapped at the stacking/running gel interface of polyacrylamide gels and electrolyte secretion as short-circuit current (Isc).	Glucosamine	43-54	LOC100508689	Homo sapiens	0-5	
7515824-4	1994	We examined the effects of interferon-gamma 1) on mucin exocytosis, measured as release of [3H]glucosamine-labeled macromolecules trapped at the stacking/running gel interface of polyacrylamide gels, and 2) on mucin biosynthesis, examined at the RNA level using a cDNA probe directed to the MUC2 mucin gene.	Glucosamine	95-106	LOC100508689	Homo sapiens	50-55	
1383042-7	1992	At low sulfate content in the medium and in the presence of chlorate, the incorporation of sulfate and glucosamine was mainly into the low molecular-weight form of mucin.	Glucosamine	103-114	LOC100508689	Homo sapiens	164-169	
8443822-3	1993	Mucin was quantitated by [3H]glucosamine labeling and Sepharose CL-4B chromatography.	Glucosamine	29-40	LOC100508689	Homo sapiens	0-5	
8443822-10	1993	Ion-exchange (DEAE-Sephacel) chromatography of [3H]glucosamine-labeled HMG demonstrated that the acidic or basic nature of the mucin was different in all cancer cell lines tested.	Glucosamine	51-62	LOC100508689	Homo sapiens	127-132	
1511431-2	1992	Mucin was quantitated by [3H]glucosamine labeling and chromatography on Sepharose CL-4B.	Glucosamine	29-40	LOC100508689	Homo sapiens	0-5	
3664476-9	1987	Metabolic labeling using [3H]glucosamine demonstrated that high mucin variants synthesized 2-fold more mucin in the cell layer and secreted 3-fold more mucin into the culture medium than the low mucin variant.	Glucosamine	29-40	LOC100508689	Homo sapiens	64-69	
2775237-1	1989	Mucin from xenografts of LS174T human colon cancer cells was treated with anhydrous HF for 1 h at 0 degree C to give a product (HFA) with over 80% of the glucosamine and hexose removed, but retaining some galactosamine, and for 3 h at room temperature to give a product (HFB) devoid of carbohydrate.	Glucosamine	154-165	LOC100508689	Homo sapiens	0-5	
3967040-2	1985	The mucin contained 11% carbohydrate, largely as glucosamine, galactose and N-acetylneuraminic acid, and 19% lipid, of which 86% was unesterified fatty acid.	Glucosamine	49-60	LOC100508689	Homo sapiens	4-9